Skip to main content

Slagle Financial, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 1984918 Edwardsville, IL

Position in GILD

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$220,715
-$28,060 QoQ
Shares Held
1,747
-2.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,866
of 2,266 holders
Holding Since
Jun 2023
13 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in GILD Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Slagle Financial, LLC holds $9,819,740 across 7 Drug Manufacturers - General names. GILD ranks #7 (2.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
7 GILD
Gilead Sciences, Inc.
This page
1,747 $220,715

All Filings in GILD

Export CSV
13 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $220,715 1,747
2026-03-31 $248,775 1,785
2025-12-31 $235,169 1,916
2025-09-30 $248,640 2,240
2025-06-30 $251,674 2,270
2025-03-31 $261,748 2,336
2024-12-31 $2,597,813 28,124
2024-09-30 $2,265,692 27,024
2024-06-30 $1,761,698 25,677
2024-03-31 $1,803,561 24,622
2023-12-31 $4,142,041 51,130
2023-09-30 $1,925,358 25,692
2023-06-30 $1,885,517 24,465